跳到正文
HHorinouchi· @HHorinouchi · X·· 2 天前评分60
正文 · 原文

🆙 #ESMO26 Proffered Paper I: #LCSM Mets 🔥SARON: Primary Results of a Randomised-Controlled Trial of Consolidation Radiotherapy for Synchronous Oligometastatic Non-Small Cell Lung Cancer 🎙️Dr. Fiona McDonald 🔢2613O 🎯SACT+RT Improved PFS (13.9 vs 8.9m, HR 0.64, p=0.03) and 12-Mo Local Failure (13.0% vs 39.5%) 🎯No OS Benefit (31.0 vs 28.0mo, HR 0.99) ☑️NCT02417662 🔗 https://t.co/uGHKJfiJGo @OncoAlert @Larvol @myESMO @IASLC

热度 1 · 0 赞 · 0 回复 · 1 转发

会议摘要

来源:HHorinouchi · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org